Dilantin Stevens Johnson Syndrome
Stevens Johnson Syndrome (SJS) is a rare inflammatory skin disorder that can be fatal. It causes lesions in the mouth, eyes, and on the body, and can spread to the internal organs. Although the majority of cases occur in people between the ages of 20 and 40, SJS can occur at any age.
Permanent skin damage and scarring can occur. Lesions and blisters that occur internally on organs can cause serious inflammation of the lungs, heart, and kidneys. Up to 27 percent of those afflicted with Stevens Johnson Syndrome or related illnesses incur long- term eye damage or vision loss. As many as 15 percent of those who develop the syndrome will die from the condition.
Dilantin & SJS
Since 1998 there have been a significant number of reports of children reported to have SJS caused by anticonvulsants, including Dilantin. In addition it has been reported that a significant number of hospitalized patients developed Stevens Johnson Syndrome associated with antiepileptics, mostly from Dilantin.
Estimates of risk of SJS associated with anticonvulsants such as Dilantin were recently published showing that the incidence of Dilantin Stevens Johnson Syndrome was higher than some of the other available anticonvulsants.
Although it is a somewhat rare condition, Stevens Johnson Syndrome is a frightening and extremely serious syndrome. The condition can rapidly progress from widespread rash, to blisters and lesions across the body resembling second-degree burns. The reaction spreads throughout the body via the skin and/or mucous membranes, including internally where it affects the organs.
Contact us for help
If you have questions about Dilantin Stevens Johnson Syndrome, or if you or a loved one has been diagnosed with SJS due to taking Dilantin, contact Greg Jones & Associates. You may qualify to recover for damages or remedies.









